OTLC

$0.03-0.99%website ↗

Oncotelic Therapeutics, Inc.

Market Cap

$14M

Sector

Materials

Industry

Biotechnology

Beta

-0.10

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

7 analysts

Velocity Score

25.65x

Current Rate (90d)

9452.88/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

3

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-01	2026-07-02	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	240.0K	$0.04	$10K	94.12M	View
2026-06-24	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	115.0K	$0.04	$5K	93.88M	View
2026-06-23	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	75.0K	$0.04	$3K	93.77M	View
2026-06-22	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	65.0K	$0.04	$3K	93.69M	View
2026-06-22	2026-06-22	Shah Amit B.	CFO	Purchase	20.0K	$0.05	$1K	378.8K	View

1–5 of 10

1 / 2

Recent News

Oncotelic Therapeutics, Inc. to Present at the OTCQB Virtual Investor Conference on August 6th

Yahoo Finance · 2026-08-03

Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003

Yahoo Finance · 2026-06-29

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

Yahoo Finance · 2026-06-17

Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote

Yahoo Finance · 2026-06-08

Informational purposes only, not investment advice.